We are live on ! Find out more
FLGT icon

Fulgent Genetics

35 hedge funds and large institutions have $30.6M invested in Fulgent Genetics in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

245% more capital invested

Capital invested by funds: $8.85M → $30.6M (+$21.7M)

150% more funds holding

Funds holding: 1435 (+21)

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

8.73% more ownership

Funds ownership: 7.11%15.84% (+8.7%)

Holders
35
Holders Change
+21
Holders Change %
+150%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
6
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change

FLGT Hedge Fund Activity: Q3 2019 in Review

35 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2019, worth a combined $30.6M — up 245% from $8.85M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new FLGT positions and 0 closed out — a net gain of 21 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Raymond James Trust, opening a new position worth an estimated $4.74M. The largest seller was Mutual Advisors, cutting an estimated $662K.

  • 35 institutional investors held Fulgent Genetics (FLGT) as of Q3 2019, up from 14 in Q2 2019.
  • Funds reported $30.6M of Fulgent Genetics stock for Q3 2019, up 245% quarter-over-quarter.
  • 21 funds opened new Fulgent Genetics positions in Q3 2019 and 0 closed out, a net change of +21 holders.
  • The largest Fulgent Genetics buyer in Q3 2019 was Raymond James Trust, an estimated $4.74M added.
  • The largest Fulgent Genetics seller in Q3 2019 was Mutual Advisors, an estimated $662K sold.

Based on aggregated 13F filings for Q3 2019.